logo-alt.png
Global COVID-19 Impact on Vaccines & Drugs Market growth is mainly attributed due to growing number of people infected with COVID-19 and rising funding for vaccine development - PMI
22 juin 2020 11h05 HE | PMI
Covina, CA, June 22, 2020 (GLOBE NEWSWIRE) -- The global COVID-19 vaccines market accounted for US$ 2.6 billion in 2020 and is estimated to be US$ 1.5 billion by 2025 and is anticipated to register...
Minerva logo
Minerva Neurosciences Announces Positive Top Line Results in Phase 2b Clinical Trial With Seltorexant (MIN-202) in Treatment of Depressed Patients With an Inadequate Response to SSRIs and SNRIs
13 mai 2019 08h15 HE | Minerva Neurosciences, Inc
Potential first-in-class, oral specific orexin-2 inhibitor demonstrates statistically significant improvement in MADRS scores at 6 weeks compared to placebo Well tolerated, with adverse events similar...
BES_Mark.jpg
Bragar Eagel & Squire, P.C. is Investigating Johnson & Johnson (JNJ) on Behalf of Stockholders and Encourages JNJ Investors to Contact the Firm
14 déc. 2018 18h45 HE | Bragar Eagel & Squire
NEW YORK, Dec. 14, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Johnson & Johnson (NYSE: JNJ).  Our investigation concerns whether Johnson...
biosig_rgb.png
Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations
09 janv. 2018 08h00 HE | BioSig Technologies, Inc.
Santa Monica, CA, Jan. 09, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to...
CURE Logo.png
CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development
09 mai 2017 09h00 HE | CURE Pharmaceutical
OXNARD, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology company researching cannabinoid molecules for various...
Landor_bk_rgb.jpg
Established CPG Brands Named Most Engaging According to Landor Pulse
25 avr. 2017 10h00 HE | Landor
NEW YORK, April 25, 2017 (GLOBE NEWSWIRE) -- When it comes to consumer packaged goods (CPG), established personal care and food brands—rather than newcomers born in the age of social media—dominate...
SPR Therapeutics LOGO 361 TM.jpg
SPR Therapeutics Appoints Michael P. Chuisano to Board of Directors
21 mars 2017 09h33 HE | SPR Therapeutics, LLC
CLEVELAND, March 21, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, LLC, a private medical device company that has developed a novel, evidence-based neurostimulation platform for chronic and acute pain,...
Antimicrobial Coatin
Antimicrobial Coatings Market To Focus On R&D For Future Innovations As Super-Resistant Microbes Develop - IndustryARC
09 mars 2017 09h00 HE | IndustryARC
Hyderabad, March 09, 2017 (GLOBE NEWSWIRE) -- The report “Antimicrobial Coatings Market: By Product Type (Antimicrobial Powder Coatings, Surface Modifications and Coatings) By End-User (HVAC,...
Agile_Logo-color on white.jpg
Agile Therapeutics Announces Positive Top-line Phase 3 Results
03 janv. 2017 16h11 HE | Agile Therapeutics, Inc.
Resubmission of Twirla® New Drug Application Expected to Address FDA’s Complete Response LetterCompany Plans to Resubmit NDA in First Half of...
Ralph Scozzafava
Boyden's Leadership Series Features Dean Foods’ Ralph Scozzafava
31 août 2016 05h45 HE | Boyden
DALLAS, Aug. 31, 2016 (GLOBE NEWSWIRE) -- Boyden, a global leader in executive search, today released a new issue of its Leadership Series, featuring an in-depth interview with Ralph Scozzafava,...